Dermatitis
- Crisaborole Improves Sleep Disruption in Children With Eczema
- Half of Patients With Moderate-to-Severe AD Have Inadequate Disease Control
- Corneum Lipid, Cytokine Profiles at 2 Months Predict AD Onset in Children
- Positive Allergen Patch Test More Likely With Atopic Dermatitis
- Atopic Dermatitis Itch, Sleep Symptoms Improved With Lebrikizumab
- In Prurigo Nodularis, Dupilumab Achieves Clinically Meaningful Improvement
- New Atopic Dermatitis Algorithm Matches FDA-Approved Treatment to Patient
- Increase in Perioral Dermatitis May Be Linked to Mask Use During COVID-19 Pandemic
- Some Skin Surface Biomarkers Can Help Predict Atopic Dermatitis in Children
- Tapinarof Cream Eases Atopic Dermatitis in Patients as Young as 2 Years
- Dupilumab Effective for Treating Erythrodermic Atopic Dermatitis
- Disease Burden Measurement Tool Performance Depends on Eczematous Disease Area
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
